Publicaciones en colaboración con investigadores/as de Hospital Regional Universitario de Málaga (24)

2024

  1. Attributable mortality of infections caused by carbapenem-resistant Enterobacterales: results from a prospective, multinational case-control-control matched cohorts study (EURECA)

    Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, Vol. 30, Núm. 2, pp. 223-230

2023

  1. Risk factors for infections caused by carbapenem-resistant Enterobacterales: an international matched case-control-control study (EURECA)

    eClinicalMedicine, Vol. 57

2020

  1. Erratum to Spanish Guidelines on the Evaluation and Diagnosis of Bronchiectasis in Adults [Arch Bronconeumol. 2018;54(2):79–87] (Archivos de Bronconeumologia (2018) 54(2) (79–87), (S0300289617302727), (10.1016/j.arbres.2017.07.015))

    Archivos de Bronconeumologia

  2. Impact of pseudomonas aeruginosa infection on patients with chronic inflammatory airway diseases

    Journal of Clinical Medicine, Vol. 9, Núm. 12, pp. 1-32

2019

  1. Bronchiectasis: When the Published Scientific Evidence Proves Insufficient

    Archivos de Bronconeumologia

2018

  1. Antibiotic selection in the treatment of acute invasive infections by pseudomonas aeruginosa: Guidelines by the Spanish society of chemotherapy

    Revista Espanola de Quimioterapia, Vol. 31, Núm. 1, pp. 78-100

  2. Management of multidrug resistant Gram-negative bacilli infections in solid organ transplant recipients: SET/GESITRA-SEIMC/REIPI recommendations

    Transplantation Reviews, Vol. 32, Núm. 1, pp. 36-57

  3. Spanish Guidelines on Treatment of Bronchiectasis in Adults

    Archivos de Bronconeumologia, Vol. 54, Núm. 2, pp. 88-98

  4. Spanish Guidelines on the Evaluation and Diagnosis of Bronchiectasis in Adults

    Archivos de Bronconeumologia, Vol. 54, Núm. 2, pp. 79-87

2017

  1. Antibiotic resistance and population structure of cystic fibrosis Pseudomonas aeruginosa isolates from a Spanish multi-centre study

    International Journal of Antimicrobial Agents, Vol. 50, Núm. 3, pp. 334-341

  2. Individual patterns of complexity in cystic fibrosis lung microbiota, including predator bacteria, over a 1-year period

    mBio, Vol. 8, Núm. 5

2016

  1. Bronchopulmonary infection-colonization patterns in Spanish cystic fibrosis patients: Results from a national multicenter study

    Journal of Cystic Fibrosis, Vol. 15, Núm. 3, pp. 357-365

  2. Comprehensive clinical and epidemiological assessment of colonisation and infection due to carbapenemase-producing Enterobacteriaceae in Spain

    Journal of Infection, Vol. 72, Núm. 2, pp. 152-160

2015

  1. Spanish Consensus on the Prevention and Treatment of Pseudomonas aeruginosa Bronchial Infections in Cystic Fibrosis Patients

    Archivos de Bronconeumologia, Vol. 51, Núm. 3, pp. 140-150

2014

  1. Microbiological diagnostic procedures for respiratory cystic fibrosis samples in Spain: Towards standard of care practices

    BMC Microbiology, Vol. 14, Núm. 1

2013

  1. Inhaled antibiotics for the treatment of chronic bronchopulmonary Pseudomonas aeruginosa infection in cystic fibrosis: Systematic review of randomised controlled trials

    Expert Opinion on Pharmacotherapy, Vol. 14, Núm. 9, pp. 1135-1149

2011

  1. Trends in yearly prevalence of third-generation cephalosporin and fluoroquinolone resistant Enterobacteriaceae infections and antimicrobial use in Spanish hospitals, Spain, 1999 to 2010

    Eurosurveillance, Vol. 16, Núm. 40

2008

  1. Diagnosis and treatment of bronchiectasis

    Archivos de Bronconeumologia, Vol. 44, Núm. 11, pp. 629-640

  2. Prevalencia de infecciones por Acinetobacter baumannii resistente a carbapenemas en España (1999-2005)

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 26, Núm. 4, pp. 199-204

2007

  1. Etiología y resistencias a los antibióticos en las infecciones de piel y partes blands

    Medicina Preventiva, Vol. 13, Núm. 1, pp. 20-26